PharmEasy-Owned Thyrocare’s Q4 Profit Jumps 25.6% To INR 21.6 Cr

PharmEasy-owned diagnostics platform Thyrocare’s consolidated net profit zoomed 25.6% to INR 21.6 Cr in the fourth quarter of the financial year ended March 2025 (Q4 FY25) from INR 17.2 Cr in the year-ago quarter.

Sequentially, profit increased 14% from INR 18.95 Cr. 

Meanwhile, the company’s consolidated operating revenue grew 21.3% to INR 187.2 Cr during the quarter under review from INR 154.3 Cr in Q4 FY24. The topline rose 12.8% quarter-on-quarter (QoQ) from INR 165.9 Cr. 

Thyrocare’s…